Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-255,778
Closed -$9.34M 246
2020
Q2
$9.34M Sell
255,778
-11,763
-4% -$409K 0.76% 44
2020
Q1
$8.18M Buy
267,541
+6,630
+3% +$294K 0.77% 47
2019
Q4
$13.3M Buy
260,911
+6,137
+2% +$296K 1.02% 30
2019
Q3
$12M Buy
254,774
+4,669
+2% +$223K 1.02% 31
2019
Q2
$12.4M Buy
250,105
+3,436
+1% +$162K 1.13% 28
2019
Q1
$10.5M Buy
246,669
+20,831
+9% +$921K 0.99% 31
2018
Q4
$9.27M Sell
225,838
-12,929
-5% -$555K 1% 31
2018
Q3
$11.2M Buy
238,767
+7,737
+3% +$354K 1.18% 28
2018
Q2
$10.1M Buy
231,030
+2,608
+1% +$122K 1.14% 29
2018
Q1
$10.5M Buy
228,422
+3,135
+1% +$152K 1.21% 30
2017
Q4
$11.4M Buy
225,287
+3,688
+2% +$194K 1.31% 28
2017
Q3
$11.5M Sell
221,599
-25,250
-10% -$1.23M 1.4% 25
2017
Q2
$12.1M Buy
246,849
+2,286
+0.9% +$106K 1.53% 18
2017
Q1
$11.5M Buy
244,563
+98,443
+67% +$4.69M 1.51% 21
2016
Q4
$7.02M Buy
146,120
+6,317
+5% +$290K 1.15% 23
2016
Q3
$5.54M Sell
139,803
-2,018
-1% -$75.9K 1% 29
2016
Q2
$5.04M Buy
+141,821
New +$5.53M 0.86% 32

Other funds holding MET

GW & Wade's MET Position: Q3 2020 in Review

GW & Wade sold out of MetLife (MET) in Q3 2020, closing a stake of 255,778 shares — an estimated $9.34M sold.

GW & Wade first reported a position in MET in Q2 2016 and held it in 17 quarters. The position peaked at $13.3M in Q4 2019. 961 funds tracked by Wall St. Rank hold MET as of Q3 2020.

  • GW & Wade reported no remaining MetLife position as of Q3 2020 after selling out during the quarter.
  • GW & Wade sold 255,778 MetLife shares in Q3 2020, an estimated $9.34M.
  • GW & Wade first reported a position in MetLife in Q2 2016 and held it in 17 quarters.
  • GW & Wade's MetLife position peaked at $13.3M in Q4 2019.
  • 961 funds tracked by Wall St. Rank held MetLife as of Q3 2020.

Based on GW & Wade's 13F filing for Q3 2020, filed 9 Nov 2020.